Combo Drug for Childhood Asthma Appears Safe in Study

Combo Drug for Childhood Asthma Appears Safe in Study


Asthma Attack Treatment

News Picture: Combo Drug for Childhood Asthma Appears Safe in StudyBy Dennis Thompson
HealthDay Reporter

WEDNESDAY, Aug. 31, 2016 (HealthDay News) — Lingering safety concerns regarding an asthma drug for children may be put to rest by new clinical trial results showing the widely used medication is safe, according to a new report.

Long-acting beta agonists (LABAs) provide short-term relief of asthma symptoms by relaxing and opening the airways. They’re prescribed to child asthma sufferers in combination with an inhaled steroid drug to reduce airway inflammation, said study co-author Dr. Stanley Szefler. He is director of pediatric asthma research for the University of Colorado School of Medicine.

“Together they have a dual purpose, one to reduce inflammation and the other to open up the airways to make it easier to breathe,” Szefler said.

But a 2008 analysis by the U.S. Food and Drug Administration questioned the safety of LABAs, noting that some studies had found an increased risk of asthma-related